CDEK
← All organizations

Crown Laboratories, Inc.

For profitWebsite ↗

Also known as: CROWN LABS | CROWN LABS INC

Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 2

First clinical trial

Apr 25, 2017

First marketed drug

Jun 1, 2000

Last known activity

Dec 26, 2017

Timeline

1980s

  1. Mar 19, 1984

    triamcinolone— Marketing Organization

2000s

  1. Jun 1, 2000

    Crown Laboratories, Inc.— Founded

2010s

  1. Jan 5, 2018

    Vita Liberata Ltd.— Acquired

  2. Sep 27, 2018

    Bellus Medical— Acquired

  3. May 21, 2019

    Xycrobe Therapeutics— Acquired

2020s

  1. Aug 13, 2024

    Revance Therapeutics, Inc.— Acquired

Drugs by trial phase (4 distinct, 29 trials)

Phase 4 (0 own, 1 via acquisition)

Phase 3 (0 own, 1 via acquisition)

Phase 2 (1 own, 1 via acquisition)

Indications

Studied for

Marketed drugs (3)

Subsidiaries (4 direct, 4 total across the full acquisition tree)

Recent trials (1)

Details

Founded
Johnson City, TN, US Jun 1, 2000
Last known activity
Dec 26, 2017